Several analysts have recently updated their ratings and price targets for Aduro BioTech (NASDAQ: ADRO): 5/17/2016 – Aduro BioTech had its price target lowered by analysts at FBR & Co. from $30.00 to $22.00. They now have an “outperform” rating on the stock. 5/17/2016 – Aduro BioTech had its “outperform” rating reaffirmed by analysts at […]
